Literature DB >> 24831978

VeriStrat validated in patients with non-small-cell lung cancer.

Charles A Butts1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24831978     DOI： 10.1016/S1470-2045(14)70203-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Erlotinib therapy after initial platinum doublet therapy in patients with EGFR wild type non-small cell lung cancer: results of a combined patient-level analysis of the NCIC CTG BR.21 and SATURN trials.

Authors:  Raymond U Osarogiagbon; Federico Cappuzzo; Tudor Ciuleanu; Larry Leon; Barbara Klughammer
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Multiplexed measurement of candidate blood protein biomarkers of heart failure.

Authors:  Claire Tonry; Ken McDonald; Mark Ledwidge; Belinda Hernandez; Nadezhda Glezeva; Cathy Rooney; Brian Morrissey; Stephen R Pennington; John A Baugh; Chris J Watson
Journal:  ESC Heart Fail       Date:  2021-03-28

Review 3.  The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer.

Authors:  Claire L Tonry; Emma Leacy; Cinzia Raso; Stephen P Finn; John Armstrong; Stephen R Pennington
Journal:  Diagnostics (Basel)       Date:  2016-07-18

Review 4.  Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives.

Authors:  Xinghua Cheng; Haiquan Chen
Journal:  Onco Targets Ther       Date:  2014-09-23       Impact factor: 4.147
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.